🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#dagtegenkanker dank Jean Bosco Safari voor een prachtoptreden op dagzaal oncologie Jan Palfijn, Antwerpen! ZNA-Woordvoerder

📢Today is #NETCancerDay! Created by INCA over 10 years ago, #NETCancerDay is held to raise awareness and improve NET diagnostics and care. Know the Symptoms. Push for Diagnosis! 📌Join us and spread the word: ▶incalliance.org/ncd-2022/ #LetsTalkAboutNETs #MedTwitter #OncoTwitter

Interesting paper delving into #neuroendocrinecancer heterogeneity. Using 42 samples of a single patient, Tamsin Robb shows different clones in different metastatic sites. Would this be driven by treatment 🤔?

This is going to be a very interesting topic! Looking forward to what Jaume Capdevila and Mauro Cives will share with us! Join us on this great discussion. #Webinars ENETS N&D Group

Proud and excited to share the start of the SAUNA trial, an academia-initiated RCT in 20 🏥🏨🏩 in 🇳🇱🇧🇪 headed by NETwerk Timon Vandamme and Erasmus MC: continue SSA💉 or not in 2nd line for non-functioning GEP NET🦓 ZonMw @kcefgpv annemiek walenkamp Koen Dreijerink clinicaltrials.gov/ct2/show/NCT05…

🔬 In ons universitair #kanker-onderzoekscentrum CORE CORE UAntwerpen UZA werken we aan nieuwe behandelingen van de toekomst, op maat van de patiënt. Graag eens een kijkje? 🎬👇 Meer info: oncopolis.be Retweet gerust, het is tenslotte hoopvol nieuws.

Quite possibly the best review of functional pancreatic neuroendocrine tumors (and their management) that I've ever read Bravo ENETS! onlinelibrary.wiley.com/doi/10.1111/jn…

Kick-off congress DBNETS (Dutch Belgian Neuroendocrine Tumor Society) Rotterdam#Hans Hofland#settling the scopes👊👊👍👍

DBNETS Rotterdam#Annemiek Walenkamp NET expert#always enthousiastic and expiring talks💥💥

Vanavond mochten we, samen met Vzw NET en MEN Kanker Belgium, een praatje houden over ons werk voor de patiënten bij het DB-nets congres in Rotterdam. DB-nets is een samenwerking van alle Nederlandse en Belgische kenniscentra voor NET en NEC.

Really enjoyed the first Dutch Belgian NET Society conference. Truely a constructive, collaborative and relaxing atmosphere. Thanks to the amazing board and all participants DBNETS annemiek walenkamp Timon Vandamme Koen Dreijerink NETNECkanker Willem Lybaert Christophe Deroose @DerksJules @Dingemans_AnneM

What is the carcinoid syndrome😳? Many mediators have been postulated, but what is truly the evidence? See our new review Endocrine Society Journals academic.oup.com/edrv/advance-a… Erasmus MC DBNETS Neuroendocrine Cancer

Today is all about #neuroendocrinecancer at #ENDIMET2024, the largest medical conference in Colombia with 3000+ participants. Happy to be invited to talk about the NET treatment algorithm and the role of somatostatin analogues in grade 3 NET @aceendocrino #launiónhACElafuerza

Willem Lybaert Mauro Cives Thor Halfdanarson First-line trial with DLL3-BITE and carbo/eto for extra-pulmonary neuroendocrine carcinoma and large cell NEC of lung currently open and recruiting in UZA & NETwerk. Hopefully promise will be translated to new standard-of-care in this hard-to-treat cancer!

Op donderdag 3 oktober was in Antwerpen het DBNETS-congres. Dit congres is bedoeld voor Nederlandse en Belgische specialisten op het gebied van NET en NEC. De Belgische patiëntenvereniging vzw NET & MEN Kanker en wijzelf mochten het congres afsluiten.

Important alert: 🚨 The COMPETE study has met its primary endpoint! ITM-11, a targeted radiopharmaceutical therapy, demonstrated a clinically relevant and statistically significant improvement in PFS compared to everolimus in patients with G1-G2 GEP-NETs itm-radiopharma.com/news/press-rel…

Functional imaging in NECs and much more... Check out this excellent paper. Lots of goodies in here such as >90% of NECs and G3 NETs FDG PET pos. Also, 66% of NECs pos on SSTR PET. What does that mean? The SSTR is not (yet) a good NEC target. Willem Lybaert erc.bioscientifica.com/view/journals/…

Today is a good day! Our new paper on a Belgian cohort of 283 high grade neuroendocrine neoplasms receives Thor Halfdanarson's stamp of approval. More on NET G3 vs NEC, functional imaging,... through erc.bioscientifica.com/view/journals/… NETwerk Willem Lybaert

Outcomes of ICI following alkylator therapy presented by Louis de Mestier ENETS. High TMB and dMMR predicts outcomes. This took a village to do but thanks to the very collaborative NET family, it got done!

#enets2025 ENETS-INCA joint session Thor Halfdanarson on Meaningful involvement of pts in NEN research Meredith Cummins NeuroEndocrine Cancer Australia on pts partnering 🌎 Timon Vandamme on aligning researcher & pt priorities Simron Singh on improving global research 🔑Essential to partner w advocates